One sentence summary: Yeast isolates from the Metschnikowia clade retrieved from the floral nectar of diverse wild plants and their insect pollinators were found to be highly susceptible to azole antifungals widely used in agriculture and medicine.
INTRODUCTION
Azoles are currently the largest and most widely used class of antifungal agents in clinical medicine (Sheehan, Hitchcock and Sibley 1999; Pierce et al. 2013; Allen et al. 2015) , and also represent a mainstay for crop protection and material preservation (Hof 2001; Groenier and Lebow 2006; Price et al. 2015) . Their mechanism of action is mainly based on the alteration of cell membrane structure and function through interference with the biosynthesis of ergosterol, but alterations in nutrient transport and other pleiotropic effects not yet fully understood have also been described (Ghannoum and Rice 1999; Price et al. 2015; Sanguinetti, Posteraro and Lass-Flörl 2015) .
Recently, azole resistance has been increasingly reported in many fungal pathogens of animals and plants, which is a cause of great public concern (Serfling, Wohlrab and Deising 2007; Chakrabarti 2011; ECDC 2013; Vermeulen, Lagrou and Verweij 2013; Price et al. 2015) . For some of such pathogens, it has been suggested that antifungal resistance can arise during prolonged treatment or, alternatively, through exposure of the microorganism to sub-lethal concentrations of the compounds in the environment (ECDC 2013) . Moreover, azole residues can disperse and persist in the environment (Kahle et al. 2008; Battaglin et al. 2011; Bollmann et al. 2014 ) and potentially affect non-pathogenic or even beneficial fungi, and may therefore have a considerable impact on ecosystem health and functionality. However, there is very little information on the tolerance of non-target fungal species to medical and agricultural azoles, and risk assessments for antifungal use do not take into account their effects on entire fungal communities (Dijksterhuis et al. 2011; Dimitrov et al. 2014) .
The Metschnikowia clade (Saccharomycetales) consists of an ancient and diverse group of ascomycetous yeasts harboring around 50 Metschnikowia species; the three species of genus Clavispora and several asexual forms currently assigned to the genus Candida (Lachance 2011; Guzmán, Lachance and Herrera 2013) . Members of this clade are adapted to a wide variety of habitats, including flowers and their pollinators (e.g. Metschnikowia gruessii, M. proteae and M. reukaufii), plant surfaces, fruits and agricultural soils (e.g. M. pulcherrima) and aquatic environments (e.g. M. bicuspidata) (Lachance 2011; Guzmán, Lachance and Herrera 2013) . Also, some Metschnikowia species are being used in agriculture since they are highly effective in the control of plant pathogens (Piano et al. 1997; Kurtzman and Droby 2001; Sipiczki 2006) . The widespread presence of Metschnikowia species in natural and agricultural plant communities makes them a potential accidental target for azole antifungals. However, except for some reference strains from culture collections and a few clinical and agricultural isolates (Jawich et al. 2006; Desnos-Ollivier et al. 2012; Savini et al. 2013; Cordero-Bueso, Arroyo and Valero 2014) , little is known about the possible effects that azoles might have on this ecologically important fungal group.
Floral nectar is a sugary solution essential for the attraction of pollinators that provide a key ecosystem service (Kearns, Inouye and Waser 1998; Vanbergen and the Insect Pollinators Initiative 2013) . But nectar is also a crucial habitat for nectarivorous members of the Metschnikowia clade (Brysch-Herzberg 2004; Herrera et al. 2010) , and this group of yeasts seems to play important ecological functions, including the attraction of pollinators (Herrera, Pozo and Medrano 2013; Schaeffer and Irwin 2014; Pozo, Lievens and Jacquemyn 2015) . It is well known that pesticides, chemical residues and azoles can accumulate in floral nectar and may have sublethal effects on plant pollinators (Rortais et al. 2005; Desneux, Decourtye and Delpuech 2007; Wallner 2009; Blacquière et al. 2012; Bernauer, Gaines-Day and Steffan 2015) . However, the impact of such anthropogenic contaminants on nectar yeast communities has not been investigated to date.
In this study, we determined the susceptibility of a large collection of strains from the Metschnikowia clade isolated from the floral nectar of diverse wild plants and their insect pollinators to a number of azole antifungals that are widely used in agriculture (epoxiconazole and imazalil) and medicine (ketoconazole and voriconazole). Imazalil and ketoconazole are two imidazoles, i.e. compounds containing two nitrogen atoms in the azole ring, whereas epoxiconazole and voriconazole belong to the triazoles and have three nitrogen atoms in the azole ring (Sheehan, Hitchcock and Sibley 1999) . Minimum inhibitory concentrations (MICs) were determined by a modification of the reference European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution (BMD) method. In addition, as antifungal susceptibility testing of yeasts from the Metschnikowia clade is still rarely performed, we explored the effect of some specific parameters (incubation time, MIC end point and culture medium) on the performance of the EUCAST method for this yeasts group.
MATERIALS AND METHODS

Isolates
A total of 120 strains from the Metschnikowia clade, most of which were obtained and identified to the species level by molecular methods in the course of previous studies (Pozo, Herrera and Bazaga 2011; de Vega et al. 2012 de Vega et al. , 2014 Pozo, Lachance and Herrera 2012; Jacquemyn et al. 2013; Lenaerts et al. 2015) , were tested (Table S1 , Supporting Information). Studied strains belonged to the following six species: M. reukaufii (n = 46); M. proteae (n = 23); M. gruessii (n = 22); M. koreensis (n = 11); M. caudata (n = 7); and Candida rancensis (n = 11). Most strains originated from the floral nectar of wild plants (87.7% of total, excluding type strains) and insect floral visitors (12.3%) from South Africa (44.7%), Spain (36.0%), Morocco (10.5%) and Belgium (8.8%). In addition, the type strains of the six tested species were also included in the experiments (Table S1 ). All strains were stored at −80
• C as cell suspensions in 25% glycerol stocks.
Antifungal susceptibility testing
In vitro antifungal susceptibility of strains was determined by the reference EUCAST BMD procedure guidelines for yeasts (Arendrup et al. 2012) , with some modifications in incubation conditions that had to be made for testing the strains investigated in this study (see below). RPMI 1640 (Sigma-Aldrich, Diegem, Belgium) supplemented with glucose (Sigma-Aldrich) to a final concentration of 20 g l −1 and buffered with 3-(N-morpholino)
propanesulfonic acid (Sigma-Aldrich) to a pH of 7.0 (hereafter referred to as RPMI + 2%G) was used as test medium (Arendrup et al. 2012 ). The antifungal agents tested (all purchased from Sigma-Aldrich) were the imidazoles imazalil and ketoconazole, and the triazoles epoxiconazole and voriconazole. All strains were tested at least twice on different days and C. krusei ATCC 6258 and C. parapsilosis ATCC 22019, which are two quality control strains recommended by the EUCAST method, were included in each series of experiments. Additionally, in order to assess possible differences in the performance of the EUCAST method related to the test medium, susceptibility tests were repeated for a selection of 37 strains (the seven M. caudata strains available and six strains representative of different regions and/or hosts for each of the remaining five species) using non-synthetic YM broth (1.0% dextrose, 0.5% peptone, 0.3% yeast extract, 0.3% malt extract; pH 6.2) instead of synthetic RPMI + 2%G.
Data analysis
Since no reference MIC end point has yet been established for susceptibility testing of azoles against Metschnikowia clade strains, end points of ≥50% and ≥90% of reduction in turbidity compared to the azole-free control well (i.e. partial and almost complete inhibition of growth, respectively) were determined. Essential agreement (EA) between the MIC values determined at different incubation times, or by using different test media (i.e. RPMI + 2%G and YM broth) and reading end points (50% vs. 90%) was defined as discrepancy of no more than ± 2 two-fold dilutions (Cuenca-Estrella et al. 2010) . When necessary, high offscale MIC results were converted to the next highest concentration and low off-scale MIC results were left unchanged (Pfaller et al. 2011) . Discrepancies between MIC values were classified as non-substantial differences (NSD, discrepancies of three or four two-fold dilutions) or substantial differences (SD, discrepancies of >4 two-fold dilutions) (Cuenca-Estrella et al. 2010) . Where relevant, differences among the MIC data distributions were evaluated by the Friedman's test followed by Bonferroni post-hoc comparisons, as implemented in Statgraphics Centurion XVII (Statpoint Technologies, Inc., Warrenton, VA, USA). The critical P-value was set at <0.05.
RESULTS
Optimization of the EUCAST method for yeast strains from the Metschnikowia clade
The EUCAST method for antifungal susceptibility testing recommends incubating microdilution plates for 24 ± 2 h, after which the absorbance at 530 nm of azole-free control wells should be >0.2 (Arendrup et al. 2012) . If required, test plates can be further incubated for 12-24 h, but failure to reach the threshold absorbance after 48 h is considered to represent a failed test (Arendrup et al. 2012) . A strict application of these stringent criteria was not possible in the present study, as most tested strains (including those used for quality control) displayed poor growth in RPMI + 2%G medium after 24 h of incubation at 25
• C and, in some cases, an absorbance value >0.2 was not reached until 72 h ( Fig. 1 ). In addition, although all C. rancensis strains and the quality control strains displayed enough growth in RPMI + 2%G after 48 h ( Fig. 1 ; Table 1 ; Table S2 , Supporting Information), absorbance values for some strains were still rather low (e.g. mean ± S.D. = 0.30 ± 0.02 for C. rancensis SA16, and 0.31 ± 0.03 for isolate SA25). Notably, none of the seven M. caudata isolates included in the study consistently grew in RPMI + 2%G even after extended incubation up to 96 h post-inoculum ( Fig. 1) .
In contrast, when tested in YM broth, the quality control strains and all strains tested except those belonging to M. caudata reached absorbance values >0.2 in just 24 h (Fig. 1) . Further incubation in YM broth resulted in most cases in saturated absorbance values in the drug-free wells (data not shown), thus resulting in unreliable MIC determination. For M. caudata, enough growth level for reliable MIC determination was not reached until 48-96 h, depending on the strain and test plate (Fig. 1) .
Voriconazole MIC values obtained in RPMI + 2%G medium for the quality control strains fell within the acceptable ranges provided in the EUCAST reference document (0.03-0.25 mg l −1 for C. krusei ATCC 6258 and 0.015-0.06 mg l −1 for C. parapsilosis ATCC 22019; Arendrup et al. 2012) or, for a minority of tests, differed in ≤2 two-fold dilutions (Table 1; Table S2 , Supporting Information). Obviously, due to the methodological modifications described in previous paragraphs, this comparison of voriconazole MICs for the quality control strains is tentative (the acceptable ranges given by the EUCAST document only refer to the 50% inhibition end point and incubation at 37
• C for 24 h). The reliability of epoxiconazole, imazalil and ketoconazole MIC determinations in RPMI + 2%G could not be assessed, as acceptable MIC ranges are not yet available for these antifungals; nevertheless, repeated assays for these compounds yielded consistent results (data not shown). The same can be said for MIC determinations in YM broth. In view of these results, it was concluded that for all species except M. caudata the optimal test conditions for azole MIC determination by the EUCAST procedure are 72 h of incubation in RPMI + 2%G or 24 h of incubation in YM broth. In the particular case of M. caudata, MIC values can only be reliably determined after 96 h of incubation in a nutrient rich medium such as YM broth.
In vitro susceptibility to azole antifungals of yeasts of the Metschnikowia clade Table 2 shows the azole MIC distributions for the studied strains in RPMI + 2%G medium (or YM broth, in the case of M. caudata). In general, epoxiconazole, ketoconazole and voriconazole were very active against all species tested and, regardless of the by guest on January 8, 2016
http://femsyr.oxfordjournals.org/ Downloaded from Figure 1 . Pie charts showing the percentages of isolates of the tested species which displayed enough growth for reliable azole susceptibility determination by the EUCAST method (i.e. absorbance at 530 nm >0.2 in the positive control well) at each reading time (24, 48 and 72 h for most species, and also 96 h for M. caudata, see Results) in 100% (blue sectors), ≥75% but <100% (green), ≥50% but <75% (orange), <50% but >0% (red) and 0% (black) of the test plates. Total numbers of isolates (N) and tests (n, mean ± S.D.) per species are as follows: (i) experiments using RPMI-1640 medium supplemented with 2% (w/v) glucose (RPMI + 2%G): M. reukaufii, N = 46, n = 423 (9.2 ± 1.6); M. proteae, N = 23, n = 193 (8.4 ± 0.7); M. gruessii, N = 22, n = 181 (8.2 ± 0.8); M. koreensis, N = 11, n = 102 (9.3 ± 1.1); C. rancensis, N = 11, n = 108 (9.8 ± 1.8); and M. caudata, N = 7, n = 56 (8 ± 0); (ii) experiments using yeast malt (YM) broth: M. reukaufii, N = 6, n = 48 (8 ± 0); M. proteae, N = 6, n = 51 (8.5 ± 1.1); M. gruessii, N = 6, n = 61 (10.2 ± 1.7); M. koreensis, N = 6, n = 66 (11 ± 3.2); C. rancensis, N = 6, n = 52 (8.7 ± 1.5); and M. caudata, N = 7, n = 88 (12.6 ± 0.5).
end point considered for MIC determination, >95% of strains were susceptible at concentrations ≤0.125 mg l −1 . Notably, in most cases there were no significant differences in the median MICs of epoxiconazole, ketoconazole and voriconazole (P > 0.05 in all pair-wise comparisons except epoxiconazole versus ketoconazole and epoxiconazole versus voriconazole for M. reukaufii and the 90% inhibition end point). In contrast, median MICs for imazalil were generally higher (P < 0.05 in all pair-wise comparisons except imazalil versus voriconazole for M. caudata and the 90% inhibition end point), and MIC distributions depended largely on the species and end point criteria. For example, only 68.3% and 27.5% of the total number of isolates were susceptible to ≤0.125 mg l −1 of imazalil when the partial (≥50%) and almost complete (≥90%) inhibition end points were considered, respectively. An excellent EA (100%) was observed for most species-azole combinations between the MIC values obtained by the two end point criteria considered (Table 2) . A notable exception was M. reukaufii, which yielded discrepant results for all tested antifungals: 1 NSD and 2 SD for epoxiconazole; 8 NSD for imazalil; and 1 SD for ketoconazole and voriconazole (Table 2) . Interestingly, one particular isolate (6.3.2-Y2, obtained in 2012 in Belgium from floral nectar of Pulmonaria officinalis) displayed discrepant results for all tested antifungals. In addition, two NSD were observed for M. caudata and imazalil.
Regarding the comparison of test media, for most species, azole antifungal and end point combinations, the EA between the MIC results determined after 72 h of incubation in plates containing RPMI + 2%G or 24 h in plates containing YM broth was 100% (Table 3) . Discrepancies in MIC results due to the test medium when the partial inhibition end point criterion was considered were only observed for imazalil and the species M. gruessii and M. koreensis, for which three out of the six isolates tested in each case yielded NSDs (Table 3) . Non-significant differences were also obtained for the same three M. gruessii and a single M. reukaufii isolate when tested for imazalil susceptibility considering the almost complete inhibition end point (Table 3) . Notably, isolate 6.3.2-Y2 of M. reukafii yielded SDs in the 90% end point MIC results when tested for epoxiconazole, ketoconazole and voriconazole susceptibility (Table 3) .
DISCUSSION
Controlling fungal pathogens is paramount to ensuring human and animal health, food security and preservation of wood and other materials (Hof 2001; ECDC 2013; Price et al. 2015) . However, the widespread use of azole antifungals in agriculture and medicine is leading to a significant accumulation of azole residuals in the environment (Kahle et al. 2008; Battaglin et al. 2011) , which poses a threat for the composition and/or functioning of fungal communities harboring non-target fungi (Dijksterhuis et al. 2011; Dimitrov et al. 2014 by guest on January 8, 2016
http://femsyr.oxfordjournals.org/ Downloaded from to fill this research gap, this study has provided novel information on the azole susceptibility of plant-and insect-associated strains from the Metschnikowia clade. To do so, we first had to optimize the EUCAST broth microdilution method of antifungal susceptibility testing for Metschnikowia clade yeasts. Apart from setting the incubation temperature to 25
• C, which is optimal for members of the Metschnikowia clade (see Materials and Methods), the scarce growth displayed by most tested species in RPMI + 2%G necessitated extended incubation of test plates (72 h, instead of the 24 h recommended by the EU-CAST method) for reliable determination of azole MICs. Alternatively, adequate growth for MIC determination was obtained in just 24 h when RPMI + 2%G was substituted for nutrient rich YM broth. Nevertheless, M. caudata was particularly recalcitrant to azole susceptibility testing, and MIC values for this species could only be determined when YM broth was used as test medium, and plates were read after 96 h of incubation. In general, most strains included in the present study were highly susceptible to broad-spectrum imidazole and triazole antifungals of widespread use in clinical and agricultural settings. These findings are in line with the observation of Desnos-Ollivier et al. (2012) , who tested 62 Metschnikowia isolates (belonging to 36 different species) from reference culture collections and found no resistance to the medical azoles fluconazole, itraconazole, posaconazole and voriconazole. Nevertheless, for a few M. reukaufii strains included in our study the azole MICs determined at a 90% inhibition end point were several two-fold dilutions higher than those obtained using the partial inhibition criterion. This observation points to the occurrence of a 'trailing' phenotype in some Metschnikowia strains, which is defined as the manifestation of reduced but persistent growth in broth dilution tests with azole agents at antifungal concentrations above the MIC (Lee et al. 2004) . Curiously, the trailing phenotype of M. reukaufii only appeared when susceptibility tests were performed in RPMI + 2%G but not when these were carried out in YM broth, thus confirming that this effect depends on species and strain-specific characteristics, as well as on different methodological aspects (Arthington-Skaggs et al. 2002; Agrawal et al. 2007; Coenye et al. 2008) .
It is worth noting that MICs for the imidazole imazalil for our strain collection were generally higher than those observed for the other azoles tested. A similar result was reported by Dijksterhuis et al. (2011) after performing toxicity tests to determine the effects of azoles and other fungicides on aquatic fungi and oomycetes. The reason for this lower susceptibility to imazalil is still unknown, but it might be due to a longer exposure to imazalil residues and/or the presence of higher concentrations of these in the environment. Indeed, imazalil has been extensively used in agriculture since the 1970s, while epoxiconazole was introduced 20 years later (Morton and Staub 2008; Price et al. 2015) . Typical uses of imazalil include field, glasshouse and indoor application by diverse methods (e.g. spraying, dipping and waxing) for the pre-and post-harvest control of diverse fungal pathogens (EFSA 2010). Moreover, apart from its agricultural applications, imazalil is used (sometimes under the synonym enilconazole) in veterinary medicine as a topical broad-spectrum antimycotic and also in some countries as a fungicide formulation for the disinfection of farm buildings (EMEA 1998), which constitute potential additional sources for environmental contamination (Kahle et al. 2008 ). Although most strains tested in this study were obtained from natural plant communities located relatively far from agricultural fields and human settlements, the presence of azole residues in these environments cannot be excluded and should be evaluated in future.
Floral nectar is a valuable reward for pollinators, and extensive research work has been carried out to understand its composition, availability and secretion patterns (Nicolson and Thornburg 2007; Brandenburg et al. 2009; Heil 2011; . More recently, there has been a growing interest in studying the role of floral nectar as a habitat for eukaryotic and prokaryotic microorganisms, and the effects these might have on nectar chemistry, pollinator behavior and sexual plant reproduction (see Pozo, Lievens and Jacquemyn 2015 for an updated review). In particular, it was found that Metschnikowia yeasts are widespread in the floral nectar of diverse plant families, and some species such as M. reukaufii could have a relevant role in attracting pollinators and influencing their foraging behavior (Herrera, Pozo and Medrano 2013; Schaeffer and Irwin 2014; . Another emerging focus of interest is the study of the presence of anthropogenic contaminants in floral nectar, and the impact of these on declining pollinator populations and, eventually, on plant reproduction. For example, it has been demonstrated that some insecticides such as the neonicotinoids are relatively common in nectar and can alter the physiology and behavior of pollinators (Blacquière et al. 2012; Stanley et al. 2015) . Although some studies have reported the presence of trace amounts of certain azoles in pollen and nectar collected by foraging honey bees shortly after field applications, and over a prolonged time afterwards (e.g. Wallner 2009), to the best of our knowledge, no study has analyzed so far the possible effect of these antifungal compounds on the nectar microorganismsplant-pollinator system. In any case, given the high susceptibility to azoles of nectar yeasts from the Metschnikowia clade found in this study, it seems clear that future risk assessments of the use of antifungals should pay attention to the nectar microbiota.
In summary, results of this study provide compelling evidence that exposure to azoles may pose a risk for ecologically important yeasts from the Metschnikowia clade, and thus could potentially have detrimental effects on ecosystem dynamics and key services including plant pollination. This adds yet another source of concern for the long-term persistence of healthy plantpollinator systems in natural communities. A next step would be to study the in planta effects of azoles on Metschnikowia yeasts, as well as to determine the actual ecological consequences of the in vitro results here reported.
Excellence in R&D&I [SEV-2012-0262] and 'Ayudas Fundación BBVA a Investigadores y Creadores Culturales'. ML, HJ and BL acknowledge support from FWO [G.0652.13N]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
